Useful resources |
Haloperidol versus placebo for schizophrenia (Cochrane Review) ABSTRACT Background: Haloperidol was developed in the late 1950s for use in the field of anaesthesia. Research subsequently demonstrated effects on hallucinations, delusions, aggressiveness, impulsiveness and states of excitement and led to the introduction of haloperido . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |